BIOREM today announced its results for the three and six-month periods ended June 30, 2024. BIOREM’s complete second quarter financial statements and […]
BIOREM today announced its results for the three and twelve-month periods ended December 31, 2023. Biorem’s complete fiscal 2023 year-end financial statements […]
Guelph, Ontario – November 29, 2023 – BIOREM Inc. (TSX-V: BRM) (“BIOREM” or “The Company”) today announced its results for the three […]
Biorem Reports Second Quarter Results and RecordOrder Backlog Guelph, Ontario – August 23, 2023 – BIOREM Inc. (TSX-V: BRM) (“BIOREM” or “The […]
BIOREM Inc announces that, pursuant to its incentive Stock Option Plan, it has granted incentive stock options to certain directors, of the […]
Biorem Reports Third Quarter Results & Increases in Revenues and Earnings BIOREM today announced its results for the three and nine-month periods […]
New growth initiatives drive BIOREM order backlog to record $44.5M BIOREM today announced several new orders totalling $7.1 million. The orders are […]
BIOREM Reports Second Quarter Financial Results & Record Order Backlog BIOREM today announced its results for the three and six-month periods ended […]
BIOREM order backlog grows to $40 million on strength of $11 million in new orders North American sales a “vote of confidence” […]
Biorem Reports First Quarter Financial Results GUELPH, ON, May 20, 2022 – BIOREM Inc. today announced results for the three month period […]